Cytomegalovirus reactivation after low-dose steroid treatment for hemolytic anemia in a patient with primary Epstein-Barr virus infection. (CROSBI ID 179426)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Trošelj-Vukić, Biserka ; Milotić, Irena ; Milotić, Franko ; Crnić-Martinović, Marija ; Grahovac, Blaženka
engleski
Cytomegalovirus reactivation after low-dose steroid treatment for hemolytic anemia in a patient with primary Epstein-Barr virus infection.
Cytomegalovirus reactivation is a well described event occurring after intensive therapeutic suppression of the immune function in patients with latent infection. Treatment protocols for suppression of the immune response often include high-dose steroids. However, it is not known whether even a low-dose steroid treatment can reactivate latent cytomegalovirus in otherwise healthy persons. We documented cytomegalovirus reactivation after low-dose steroid treatment for autoimmune hemolytic anemia as a complication of Epstein-Barr virus mononucleosis in an immunocompetent 21-year-old man.
Cytomegalovirus reactivation; steroid therapy; Epstein-Barr mononucleosis
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
119 (13/14)
2007.
435-437
objavljeno
0043-5325
10.1007/s00508-007-0821-4
Povezanost rada
Kliničke medicinske znanosti
